Publication: Preliminary biological evaluation of 99mTc-glucosamine as a potential radiotracer for tumor imaging
Дата
2020
Авторы
Tishchenko, V. K.
Mikhailovskaya, A. A.
Smoryzanova, O. A.
Ivanov, S. A.
Petriev, V. M.
Journal Title
Journal ISSN
Volume Title
Издатель
Аннотация
© Published under licence by IOP Publishing Ltd.The development of novel specific radiolabeled probes as targeted imaging agents for a more accurate detection of cancer has gained considerable interest. Glucose analogue 18F-FDG is used worldwide for imaging of several cancer types. New glucose analogs radiolabeled with 99mTc could be a less-expensive and more accessible alternative for diagnosis using SPECT imaging. The complex of glucosamine and 99mTc were prepared, and its biodistribution was evaluated in solid Ehrlich carcinoma bearing mice. 99mTc-glucosamine was synthesized and radiolabeled with 99mTc with high yield and stability. Biodistribution studies showed that tumor uptake of 99mTc-glucosamine increased from 0.440.06 %ID/g at 5 min postinjection (p.i.) to 0.540.06 %ID/g and 0.640.07 %ID/g at 1 h and 3 h p.i., respectively. The tumor/blood and tumor/muscle ratios also increased with time and reached 1.020.12 and 1.880.20 at 3 h p.i. 99mTc-glucosamine was rapidly removed from blood through the urinary system, so high amount of activity accumulated in kidneys. High uptake of 99mTc-glucosamine was also observed in two high-energy-dependent organs, heart and liver. In other organs such as lungs, spleen, stomach, small intestine and brain high uptake of 99mTc-glucosamine was only at 5 min after intravenous administration, but later the most part of activity was removed. In conclusion, we suggested that 99mTc-glucosamine would be a promising candidate for cancer SPECT imaging.
Описание
Ключевые слова
Цитирование
Preliminary biological evaluation of 99mTc-glucosamine as a potential radiotracer for tumor imaging / Tishchenko, V.K. [et al.] // Journal of Physics: Conference Series. - 2020. - 1439. - № 1. - 10.1088/1742-6596/1439/1/012033